These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 10948446)

  • 1. Overview of randomized trials of systemic adjuvant therapy.
    Ravdin PM
    Cancer Treat Res; 2000; 103():157-81. PubMed ID: 10948446
    [No Abstract]   [Full Text] [Related]  

  • 2. The impact of systemic therapy following ductal carcinoma in situ.
    Eng-Wong J; Costantino JP; Swain SM
    J Natl Cancer Inst Monogr; 2010; 2010(41):200-3. PubMed ID: 20956830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian ablation as adjuvant therapy for early-stage breast cancer.
    Pritchard KI
    Cancer Treat Res; 1998; 94():158-80. PubMed ID: 9587687
    [No Abstract]   [Full Text] [Related]  

  • 4. Is adjuvant tamoxifen recommended in post-menopausal node-negative breast cancer patients with high estrogen receptor values?
    Floiras JL; Hacene K; Turpin F; Spyratos F
    Int J Biol Markers; 2000; 15(2):135-8. PubMed ID: 10883886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The duration of adjuvant tamoxifen therapy.
    Bilimoria MM; Jordan VC
    Cancer Treat Res; 1998; 94():181-93. PubMed ID: 9587688
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer.
    Atkins CD
    J Natl Cancer Inst; 1998 Mar; 90(6):468-9. PubMed ID: 9521174
    [No Abstract]   [Full Text] [Related]  

  • 7. Equivalence between ovarian suppression and chemotherapy in the adjuvant treatment of endocrine-responsive breast cancer.
    Di Leo A; Buyse M
    J Clin Oncol; 2002 Apr; 20(7):1954-5. PubMed ID: 11919262
    [No Abstract]   [Full Text] [Related]  

  • 8. Duration of adjuvant tamoxifen therapy.
    Bryant J; Fisher B; Dignam J
    J Natl Cancer Inst Monogr; 2001; (30):56-61. PubMed ID: 11773293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nature of tamoxifen action in the control of female breast cancer.
    Kodama M; Kodama T
    In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary endocrine therapy in locally advanced breast cancers--the Nottingham experience.
    Mathew J; Agrawal A; Asgeirsson KS; Buhari SA; Jackson LR; Cheung KL; Robertson JF
    Breast Cancer Res Treat; 2009 Jan; 113(2):403-7. PubMed ID: 18311583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant treatment of breast cancer.
    Akerley WL
    R I Med; 1995 Sep; 78(9):250-3. PubMed ID: 7579720
    [No Abstract]   [Full Text] [Related]  

  • 12. Re: Prognosis and treatment of patients with breast tumors of one centimeter or less and negative axillary lymph nodes.
    Querci della Rovere G; Benson JR
    J Natl Cancer Inst; 2001 Sep; 93(18):1420; author reply 1421-2. PubMed ID: 11562396
    [No Abstract]   [Full Text] [Related]  

  • 13. [Letrozole vs. tamoxifen as neoadjuvant therapy for postmenopausal patients with hormone-dependent locally-advanced breast cancer].
    Novoa Vargas A; Font López KC; Amador DD
    Ginecol Obstet Mex; 2011 Sep; 79(9):553-7. PubMed ID: 21966856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Breast cancer adjuvants: results of a DUR (drug utilization research) study].
    Nuzzo A
    Suppl Tumori; 2004; 3(4):S86-7. PubMed ID: 15206223
    [No Abstract]   [Full Text] [Related]  

  • 15. Adjuvant treatment in node-negative, postmenopausal breast cancer.
    Hutchins LF; Arick CL
    Cancer Invest; 2001; 19(7):706-22. PubMed ID: 11577812
    [No Abstract]   [Full Text] [Related]  

  • 16. Adjuvant treatment for early breast cancer.
    Smith I
    Ann Oncol; 2005; 16 Suppl 2():ii182-7. PubMed ID: 15958454
    [No Abstract]   [Full Text] [Related]  

  • 17. Adjuvant endocrine therapy for premenopausal women with early breast cancer.
    Dellapasqua S; Colleoni M; Gelber RD; Goldhirsch A
    J Clin Oncol; 2005 Mar; 23(8):1736-50. PubMed ID: 15755982
    [No Abstract]   [Full Text] [Related]  

  • 18. Current controversies in breast cancer management.
    Morrow M; Jordan VC; Takei H; Gradishar WJ; Pierce LJ
    Curr Probl Surg; 1999 Mar; 36(3):163-216. PubMed ID: 10089889
    [No Abstract]   [Full Text] [Related]  

  • 19. A rose is no longer a rose.
    Henderson IC
    J Clin Oncol; 2002 Aug; 20(16):3365-8. PubMed ID: 12177095
    [No Abstract]   [Full Text] [Related]  

  • 20. Genomic alterations identified by array comparative genomic hybridization as prognostic markers in tamoxifen-treated estrogen receptor-positive breast cancer.
    Han W; Han MR; Kang JJ; Bae JY; Lee JH; Bae YJ; Lee JE; Shin HJ; Hwang KT; Hwang SE; Kim SW; Noh DY
    BMC Cancer; 2006 Apr; 6():92. PubMed ID: 16608533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.